A blanket protocol to study oral regorafenib in patients with refractory liposarcoma, osteogenic sarcoma, and Ewing/Ewing-like sarcomas
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Sarcoma Alliance for Research Through Collaboration
Start Date
February 1, 2014
End Date
July 13, 2021
Administered By
Duke Cancer Institute
Awarded By
Sarcoma Alliance for Research Through Collaboration
Start Date
February 1, 2014
End Date
July 13, 2021